本頁面由Tiger Trade Technology Pte. Ltd.提供服務

聯拓生物

0.3190
0.0000
成交量:- -
成交額:78.15萬
市值:3,450.47萬
市盈率:-0.39
高:0.3190
開:0.3190
低:0.3190
收:0.3190
52周最高:4.99
52周最低:0.2712
股本:1.08億
流通股本:2,540.82萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.8191
每股收益(LYR):-1.0219
淨資產收益率:-32.42%
總資產收益率:-21.67%
市淨率:0.17
市盈率(LYR):-0.31

資料載入中...

2024/03/12

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/12

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/12

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/11

自願退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2024/02/29

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/13

重要事件披露

Form 8-K - Current report
2024/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/27

重要事件披露

Form 8-K - Current report
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/07

重要事件披露

Form 8-K - Current report
2023/12/02

重要事件披露

Form 8-K - Current report
2023/11/30

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/31

重要事件披露

Form 8-K - Current report
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]